Evidence map›Paper›PMID 40955001›Full record

ReviewKorean journal of ophthalmology : KJO2025

An Overview of the Therapeutic Applications of Tinted Lenses Spectacles.

Masoumeh Ahadi, Afsaneh Ebrahimi, Ali Abbasi, Akmal Karimovich Matkarimov

Abstract readReview
In one paragraph

Review in Korean journal of ophthalmology : KJO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Eye Dominance and Testing Order Effects in the Circularly-Oriented Macular Pigment Optical Density Measurements.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masoumeh AhadiDepartment of Optometry, School of Rehabilitation Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Afsaneh EbrahimiDepartment of Optometry, School of Rehabilitation Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali AbbasiDepartment of Optometry, School of Rehabilitation Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Akmal Karimovich MatkarimovMaksudova Innovation Clinic, Tashkent, Uzbekistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although tinted glasses are part of the fashion and beauty world, these glasses have various therapeutic applications in normal people or people with eye and neurological problems in some cases have been ignored. Tinted spectacles produce their effects by reducing visible light transmission and filtering by removing a certain part of the spectrum and can reduce discomfort and annoyance and improve the quality of life. The therapeutic effects of these glasses are related to controlling photophobia, preventing glare and increasing contrast. These glasses are used in normal people as sunglasses, to improve sports activities, comfortable driving at night and to increase sleep quality. Colored glasses have also been widely used in people with low vision related to congenital and acquired retinal diseases and neurological diseases such as migraine, acquired brain injury, and photosensitive epilepsy. So far, numerous studies have been conducted on the beneficial and therapeutic effects of colored glasses, which sometimes report contradictory effects. In this article, we explore the therapeutic uses of colored glasses in more detail.

Indexed as

EyeglassesQuality of LifeVision DisordersVisual AcuityEquipment DesignHumansNeurological diseasesOcular diseasesOptical filtersTinted spectacles

Identifiers

PMID40955001
PMCPMC12718731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.